Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and ResistanceSreya Bagchi, Edgar G. Engleman|Annual Review of Pathology Mechanisms of Disease|2020Cited by 2.2k
Neutrophil-activating therapy for the treatment of cancerIan L. Linde, Edgar G. Engleman|Cancer Cell|2023Cited by 196
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell TransplantsJohn D. Scandling, Samuel Strober, Minnie Sarwal et al.|American Journal of Transplantation|2012Cited by 190
Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancerRu M. Wen, James D. Brooks, Jessica C. Stark et al.|Journal of Clinical Investigation|2024Cited by 41